文献速递肺外科心外重症与机械循环支持

肺动脉高压肺移植术后延长使用中心VA-ECMO

Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该单中心回顾性研究纳入2021至2024年20例因肺动脉高压行双肺移植的成人患者,术后对17例延长使用中心VA-ECMO并延迟关胸。中位ECMO支持4天,9例(45.0%)因血胸需清除,无术后血流动力学崩溃,90天和1年生存率均为100%(95%CI 83.2%-100%)。

要点

  • 肺动脉高压肺移植术后可延长中心VA-ECMO并延迟关胸。
  • 中位ECMO支持4天,45.0%患者需血胸清除。
  • 严格止血必要,所有患者90天及1年生存。

核心结论

  • 对肺动脉高压肺移植患者,术后延长中心VA-ECMO联合延迟关胸可行。
  • 鉴于血胸清除概率高,必须细致止血。

研究设计与样本

  • 回顾性单中心研究,纳入2021至2024年连续成人肺动脉高压双肺移植患者20例。

主要发现

  • 20例中术中支持为中心VA-ECMO 17例、体外循环3例。
  • 17例术后维持中心VA-ECMO并临时皮肤关闭。
  • ECMO支持中位时间4天(四分位距2-4)。
  • 9例(45.0%)在术后中心VA-ECMO期间行血胸清除。
  • 无患者术后发生血流动力学崩溃,90天和1年生存率均为100%(95%CI 83.2%-100%)。

临床怎么用

  • 对肺动脉高压肺移植术后预计心力衰竭或心功能欠佳者,可考虑延长中心VA-ECMO并延迟关胸。
  • 术后ECMO期间需警惕血胸,做好清除准备并强调细致止血。

局限性

  • 回顾性单中心设计,样本量20例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Lung transplantation (LTx) for patients with pulmonary arterial hypertension (PAH) is associated with high postoperative morbidity and mortality. Extracorporeal membrane oxygenation (ECMO) supports patients' haemodynamics during and after LTx. However, the optimal ECMO strategy, especially for patients with PAH, is debated. Here, we report our unique strategy for patients with PAH, using postoperative central veno-arterial (VA)-ECMO combined with delayed chest closure. METHODS: This was a retrospective single-centre study of consecutive bilateral lung transplantations for adult patients with PAH performed between 2021 and 2024. Patients' characteristics, perioperative ECMO strategy, and postoperative outcomes were reviewed. RESULTS: During the study period, 20 PAH patients (idiopathic or hereditary PAH [n = 17], PAH secondary to collagen disease [n = 1], pulmonary veno-occlusive disease [n = 1], and Eisenmenger syndrome [n = 1]) underwent cadaveric LTx. Intraoperative support comprised either central VA-ECMO (n = 17) or cardiopulmonary bypass (n = 3). In 17 patients, central VA-ECMO was maintained postoperatively with temporary skin closure. The reason for postoperative central VA-ECMO was anticipated post-LTx heart failure due to PAH and suboptimal cardiac function. The median duration of ECMO support was 4 days (interquartile range: 2-4). There were 9 (45.0%) haemothorax evacuations while patients were on postoperative central VA-ECMO. No patients experienced haemodynamic collapse after LTx. All patients survived during the observation period, resulting in a 100% survival rate at both 90 days and 1 year (95% confidence interval: 83.2%-100%). CONCLUSIONS: Extended postoperative central VA-ECMO and delayed chest closure were feasible for patients with PAH who underwent LTx. Meticulous haemostasis is mandatory, given the high chance of haemothorax evacuation.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kawashima M, Ijiri N, Konoeda C, et al. Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension. Eur J Cardiothorac Surg. 2025. PMID: 40758468. doi:10.1093/ejcts/ezaf256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。